Test Price
7,500 AED✅ Home Collection Available
Carrier Screening (Extended Genetic Panel) in UAE – AED 7,500
Executive Summary & Core Metrics
Clinical & Operational Metrics
- ✓ 99.9% Diagnostic Sensitivity – Ultra‑deep NGS with automated variant interpretation in an ISO 15189‑aligned molecular genetics facility.
- ✓ >500 Genes Analyzed – ACMG/ACOG‑recommended panel covering severe recessive and X‑linked conditions.
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM – 11 PM) by DHA‑licensed phlebotomists.
- ✓ Post‑Test Clinical Guidance: Complimentary telephonic consultation with a genetic counsellor within 48 h of report release.
- ✓ Insurance Direct Billing: WhatsApp pre‑verification at +971 54 548 8731. Final invoice with ICD‑10 codes.
DHA‑Licensed Executive Summary: The Extended Carrier Screening Panel (NGS) delivers 99.9% diagnostic sensitivity in an ISO 9001:2015 certified facility. All analyses are conducted at a DHA‑licensed laboratory (No. 1143) with temperature‑controlled home collection services. Full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 for health data confidentiality.
Test Overview & Methodology
Extended carrier screening analyzes over 500 genes associated with severe recessive and X‑linked conditions, providing a comprehensive risk assessment for family planning. Traditional single‑gene or small panel tests miss >90% of actionable carrier states identified by this method.
| Feature | Our Extended Panel | Common Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) + MLPA | Limited PCR/Genotyping (5‑20 variants) |
| Genes Covered | >500 genes (ACMG/ACOG‑recommended) | 1‑3 genes |
| Turnaround | 4 weeks (full analysis with counselling) | 1‑2 weeks (limited reporting) |
| ICD‑10 / LOINC Mapping | Z14.8, Z31.5, LOINC 51960‑6 | Often unreported |
| UAE Regulatory Status | DHA‑Licensed Facility (No. 1143); ISO 9001:2015 | Variable |
Physician Insight & Safety Protocols
“Carrier screening provides critical information for reproductive planning. A positive result does not indicate disease but rather an increased likelihood of passing a genetic condition to offspring. Combined with genetic counselling, these results empower couples to make informed decisions. Our team at DNA Labs UAE is committed to providing accurate, confidential, and compassionate care throughout this process.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Management Advisory
Continue all prescribed medications and preconception supplements unless explicitly instructed by your treating physician. A positive carrier result does not indicate active disease and should not prompt changes to your therapeutic regimen. Abrupt discontinuation of medications may carry serious health risks. Discuss any concerns arising from your carrier screening results with your healthcare provider before taking action.
Test Exclusion Criteria & Support Resources
- Whole blood transfusion within the past 4 weeks or active hematologic malignancy may compromise DNA extraction and sequencing quality.
- This test is designed for carrier detection in adults and is not validated for fetal diagnosis or pregnancy termination decisions without confirmatory invasive testing.
- If you experience psychological distress following result disclosure, contact your genetic counsellor or the UAE mental health support line at 800 1717.
Patient FAQ & Clinical Guidance
1. Is carrier screening mandatory before marriage in the UAE?
Direct Answer: Carrier screening is not mandatory for marriage under UAE federal law, but many emirates strongly recommend it as part of premarital health programs to identify genetic risks early.
The UAE Premarital Screening Programme primarily focuses on infectious diseases and haemoglobinopathies; however, extended carrier panels like ours are increasingly requested by couples to cover a broader range of inherited conditions. Our report is issued with full compliance to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019, ensuring your data privacy and right to genetic counselling.
2. How long does the extended carrier screening result take?
Direct Answer: The result for the extended panel is available within 4 weeks from the date the sample reaches the laboratory, due to deep sequencing of over 500 genes and detailed clinical interpretation.
The waiting period includes DNA extraction, sequencing, bioinformatic analysis, and a review session with a clinical geneticist. We prioritise a comprehensive and reliable report over a rapid incomplete result. A complimentary post‑result telephonic consultation with a genetic counsellor is provided to address any questions and reduce anxiety.
3. Will my health insurance cover the AED 7,500 cost?
Direct Answer: Many UAE insurers cover extended carrier screening when clinically indicated and pre‑authorised, but coverage depends on your policy’s maternity/genetic testing rider.
Our team handles direct billing verification via WhatsApp at +971 54 548 8731. We will review your policy, obtain any required pre‑approval, and provide you with an estimated out‑of‑pocket cost before sample collection. For policies with limited coverage, we offer flexible payment plans to ensure access to this essential health intelligence.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
- Data Protection: All genetic data is processed in accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Patient consent and clinical safety protocols adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Facility Certification: DHA Facility License No. 1143, ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
- Genetic Counselling: All result interpretations are provided by DHA‑licensed genetic counsellors and clinical geneticists.
Clinical & Logistical Metadata
| Test Name | Carrier Screening (Extended Genetic Panel) |
| Price (AED) | 7,500 |
| Turnaround Time | 4 weeks (full analysis with genetic counselling) |
| Sample Type / Matrix | Peripheral whole blood – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM – 11 PM) |
| Methodology Used | Next‑Generation Sequencing (NGS) + MLPA |
| ICD‑10‑CM Code | Z14.8, Z31.5 |
| LOINC Code | 51960‑6 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians